POST Online Media Lite Edition


Agile Therapeutics adds Seth H. Z. Fischer to its board

Staff Writer |
Princeton, N.J., USA - August 1, 2016, Princeton, N.J., USA - Agile Therapeutics, Inc., a women's health specialty pharmaceutical company, announced the appointment of Seth H. Z. Fischer to the company's board of directors.

Mr. Fischer will serve on Agile's Compensation and Nominating & Corporate Governance Committees.

Mr. Fischer has more than three decades of healthcare experience in the pharmaceutical and medical device industry. He currently serves as Chief Executive Officer and a Director of Vivus, Inc., a publicly traded biopharmaceutical company.

Mr. Fischer also serves as a member of the Board of Directors of BioSig Technologies, Inc., and is an advisor to MedHab, LLC. He has served in positions of increasing responsibility with Johnson & Johnson from 1983 until his retirement in 2012.

Most recently, Mr. Fischer served as Company Group Chairman Johnson & Johnson and Worldwide Franchise Chairman, Cordis Corporation from 2008 to 2012, and as Company Group Chairman, North America Pharmaceuticals from 2004 to 2007, which included responsibilities for Ortho-McNeil Pharmaceuticals, Janssen and Scios.

Prior to that, Mr. Fischer served as President of Ortho-McNeil Pharmaceuticals from 2000 to 2004.

His operating responsibilities encompassed the commercialization of products in multiple therapeutic categories including Topamax for epilepsy and migraine and products in the analgesic, anti-infective, cardiovascular, neurologic, psychiatric and women's health areas, including ORTHO EVRA, one of the most successful contraceptive launches in the U.S and the first ever contraceptive patch.

He earned a Bachelor of General Studies from Ohio University and served as a captain in the U.S. Air Force.


What to read next

Jennerex appoints Laurent Fischer as president and CEO
EUCODIS Bioscience appoints Thomas Fischer as new CEO
Agile Therapeutic: Al Altomari new president and CEO